Damora Therapeutics, Inc. (DMRA): SCHEDULE 13G filed May 15, 2026

Form type

SCHEDULE 13G

Filing date

May 15, 2026

Accession number

0000902664-26-002463

Filer

Damora Therapeutics, Inc. (CIK 1800315)